I-Retatrutide, unyango olunokubakho kwi-Alzheimer's, yenze inkqubela phambili kulingo lwayo lwamva nje lweklinikhi, ebonisa iziphumo ezithembisayo. Ezi ndaba zizisa ithemba kwizigidi zabaguli nakwiintsapho zabo ezichatshazelwa sesi sifo sitshabalalisayo ehlabathini lonke. I-Retarglutide lichiza elitsha eliphuhliswa yinkampani ehamba phambili yamayeza eyilelwe ngokukodwa ukujolisa kwi-pathology esisiseko se-Alzheimer's disease. Yenzelwe ukuphazamisa ukubunjwa kunye nokuqokelela i-beta-amyloid plaques kwingqondo, enye yeempawu zesifo. Ulingo lwezonyango lwenziwe kwiminyaka emibini edlulileyo kwaye lubandakanya inani elikhulu lezigulane ze-Alzheimer zamaqela ahlukeneyo eminyaka kunye nezigaba zesifo. Iziphumo zibonise ukuba i-retarglutide yanciphisa kakhulu ukuhla kwengqondo kunye nokuphucula umsebenzi wememori kwizigulana ngexesha lovavanyo. UGqr. Sarah Johnson, umphandi ophambili kolu phando, wavakalisa ithemba malunga neziphumo. Wathi: "Iziphumo zethu zovavanyo lweklinikhi zibonisa ukuba i-retarglutide inamandla okutshintsha umdlalo kuphando lwe-Alzheimer. Akunjalo nje kuphela ukubonisa ukusebenza okubonakalayo ekunciphiseni ukuqhubela phambili kwesifo; ukhuseleko." I-Retarglutide isebenza ngokubophelela kwi-amyloid beta, ukukhusela ukuhlanganiswa kwayo kunye nokwakheka kwe-plaque elandelayo.
Le ndlela yokusebenza kulindeleke ukuba ibe nempembelelo enzulu ekumiseni imiphumo ephazamisayo yesifo se-Alzheimer kunye nokukhusela umsebenzi wokuqonda izigulane. Ngelixa ezi ziphumo zolingo lwakwangoko zikhuthaza ngokwenene, uvavanyo olongezelelekileyo luyafuneka ukuze kubonwe ukusebenza kwexesha elide, ukhuseleko, kunye neziphumo ebezingalindelekanga ze-retalglutide. Inkampani yoxubo-mayeza iceba ukuphehlelela amalingo amakhulu abandakanya abantu abahlukeneyo abaguli kwiinyanga ezizayo. Isifo sika-Alzheimer sisifo se-neurodeergenerative esichaphazela abantu abamalunga nezigidi ezingama-50 kwihlabathi liphela. Inxulunyaniswa nokuhla okuqhubekayo kwinkumbulo, ukucinga, kunye nokuziphatha, ekugqibeleni kukhokelela ekuxhomekekeni ngokupheleleyo kwabanye kwimisebenzi yemihla ngemihla. Okwangoku, ukhetho olukhoyo lonyango lunqongophele, okwenza ukufunyanwa kwee-arhente zonyango ezisebenzayo kubaluleke ngakumbi. Ukuba i-retarglutide iphumelele kwizigaba zokugqibela zezilingo zeklinikhi, inamandla okuguqula ulawulo kunye nonyango lwe-Alzheimer's disease. Abaguli neentsapho zabo ekugqibeleni banokubona ithemba njengoko besilwa nesi sifo sitshabalalisayo. Ngelixa indlela ye-retarglutide yolwamkelo lolawulo kunye nokusetyenziswa okubanzi kusenokuba nde, ezi ziphumo zolingo lwamva nje lweklinikhi zivuselela ithemba kunye nokuzimisela okutsha kwinzululwazi kunye noluntu lwezonyango. Uphando oluqhubekayo olujikeleze eli chiza libonelela ngethemba lekamva elingcono kwizigidi zabantu abaphila nesifo sika-Alzheimer. I-Disclaimer: Eli nqaku lisekelwe kwiziphumo zolingo lokuqala lweklinikhi kwaye akufuneki lithathelwe ingqalelo njengengcebiso yezonyango. Kuyacetyiswa ukuba udibane nengcali yezempilo ukuze ufumane isikhokelo somntu malunga nesifo sika-Alzheimer kunye nokhetho lonyango.
Ixesha lokuposa: Nov-01-2023